Medicus Sciences Acquisition Corp. (the “Company”) (NASDAQ:MSAC), announced today that due to its inability to consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Charter”), the Board of Directors of the Company has elected to dissolve and liquidate the Company in accordance with the provisions of its Charter, and will redeem all of the outstanding Class A ordinary shares that were included in the units issued in its initial public offering (the “Public Shares”), at a per-share redemption price of approximately $10.18.
Xiaomi’s Entry To An Already Crowded EV Market Could Make Things Even Worse For Tesla
The EV king, Tesla Inc (NASDAQ: TSLA) kicked off the week by raising prices for all Model Y cars in the United States by $1,000. But last week, Bloomberg reported that Tesla has cut production at its Shanghai factory in response to intense competition and unsatisfactory growth in China.
